Skip to main content

Applied Therapeutics, Inc.

APLTDelisted Feb 3, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001697532

Applied Therapeutics, Inc. was delisted on Feb 3, 2026; its insiders filed their last Form 4 on Feb 4, 2026; 52 institutions reported holding it in 13F filings for Q4 2025, worth $5.93M in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding Applied Therapeutics, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of APLT: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders6971+2
Shares14.9M12.4M−2.57M (−17.2%)
Value$133.6M$26.0M−$107.5M (−80.5%)

New holders (15)

Institutions that held Applied Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to APLT in Q1 2022
InstitutionSharesValue% of portfolio
D. E. Shaw & Co., Inc.146,423$309.0K0.00%
Bridgeway Capital Management, LLC108,800$230.0K0.00%
AQR Capital Management LLC85,064$179.0K0.00%
HRT Financial LP48,737$102.0K0.00%
Occudo Quantitative Strategies LP34,372$73.0K0.01%
Acadian Asset Management LLC33,345$70.0K0.00%
Schonfeld Strategic Advisors LLC30,500$65.0K0.00%
Algert Global LLC28,420$60.0K0.00%
Parametric Portfolio Associates LLC26,981$57.0K0.00%
Connor, Clark & Lunn Investment Management Ltd.25,015$53.0K0.00%
JustInvest LLC20,119$42.0K0.00%
Amalgamated Bank2,828$6.00K0.00%
Amalgamated Financial Corp.2,828$6.00K0.00%
Federated Hermes, Inc.519$1.00K0.00%
Cutler Group LP220$00.00%

Sold out (13)

Institutions that held Applied Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.